Sign Up to like & get
recommendations!
0
Published in 2019 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000000861
Abstract: Background The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to ameliorate these…
read more here.
Keywords:
crossover;
candesartan metabolism;
effects telmisartan;
treatment ... See more keywords